Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2000 2
2007 1
2010 2
2011 2
2012 1
2013 3
2014 1
2015 4
2016 3
2017 1
2019 2
2020 1
2022 3
2023 3
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Extended HPV Genotyping for Risk Assessment of Cervical Intraepithelial Neoplasia Grade 2/3 or Worse in a Cohort Study.
Li X, Rao X, Wei MJ, Lu WG, Xie X, Wang XY. Li X, et al. J Natl Compr Canc Netw. 2022 Aug;20(8):906-914.e10. doi: 10.6004/jnccn.2022.7032. J Natl Compr Canc Netw. 2022. PMID: 35948040
BACKGROUND: We sought to identify the absolute risk of specific HPV genotype for cervical intraepithelial neoplasia grade 2/3 or worse (CIN2+/3+) and to develop a risk-based management strategy in an HPV-positive population. ...Compared w …
BACKGROUND: We sought to identify the absolute risk of specific HPV genotype for cervical intraepithelial neoplasia …
Posttreatment monitoring by ASCL1/LHX8 methylation analysis in women with HIV treated for cervical intraepithelial neoplasia grade 2/3.
Vink FJ, Steenbergen RDM, Kremer WW, Lissenberg-Witte BI, Heideman DAM, Bleeker MCG, van Zummeren M, Breytenbach E, Visser C, Lukhwareni A, Meijer CJLM, Dreyer G. Vink FJ, et al. AIDS. 2022 Jun 1;36(7):953-961. doi: 10.1097/QAD.0000000000003197. Epub 2022 Feb 15. AIDS. 2022. PMID: 35152224
OBJECTIVE: Women with HIV (WWH) have an increased risk to develop recurrent cervical intraepithelial neoplasia grade 2/3 (rCIN2/3) after treatment compared with HIV-negative women. ...This study evaluates the performance of ASCL1 and LHX8 …
OBJECTIVE: Women with HIV (WWH) have an increased risk to develop recurrent cervical intraepithelial neoplasia grade …
Regional differences in human papillomavirus type 52 prevalence among Japanese women with cervical intraepithelial neoplasia†.
Kukimoto I, Onuki M, Yamamoto K, Yahata H, Aoki Y, Yokota H, Konnai K, Nio A, Takehara K, Kamiura S, Tsuda N, Takei Y, Shimada M, Nakai H, Yoshida H, Motohara T, Yamazaki H, Nakamura K, Okunomiya A, Tasaka N, Ishikawa M, Hirashima Y, Shimoji Y, Mori M, Iwata T, Takahashi F, Yoshikawa H, Yaegashi N, Matsumoto K; MINT Study Group. Kukimoto I, et al. Jpn J Clin Oncol. 2022 Oct 6;52(10):1242-1247. doi: 10.1093/jjco/hyac127. Jpn J Clin Oncol. 2022. PMID: 35938523
The risk of cervical intraepithelial neoplasia progression was assessed by calculating a prevalence ratio of each human papillomavirus type for cervical intraepithelial neoplasia grade 2/3 versus grade 1. Among the human papillomavirus ty …
The risk of cervical intraepithelial neoplasia progression was assessed by calculating a prevalence ratio of each human papillomavirus type …
The 5-year risk of recurrence of grade 2/3 cervical intraepithelial neoplasia after treatment in a population screening programme by human papillomavirus status: A cohort study in central Italy.
Visioli CB, Iossa A, Gorini G, Mantellini P, Lelli L, Auzzi N, Pierro CD, Carozzi FM, Zappa M. Visioli CB, et al. J Med Screen. 2023 Dec;30(4):191-200. doi: 10.1177/09691413231175630. Epub 2023 May 25. J Med Screen. 2023. PMID: 37229655
OBJECTIVES: (a) To estimate the risk of recurrent cervical intraepithelial neoplasia, grade 2/3 or worse (CIN2+/CIN3+), lesions within 5 years of follow-up in human papillomavirus-negative/human papillomavirus-positive cohorts; (b) to ass …
OBJECTIVES: (a) To estimate the risk of recurrent cervical intraepithelial neoplasia, grade 2/3 or …
Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears.
Shlay JC, Dunn T, Byers T, Barón AE, Douglas JM Jr. Shlay JC, et al. Obstet Gynecol. 2000 Sep;96(3):410-6. doi: 10.1016/s0029-7844(00)00907-8. Obstet Gynecol. 2000. PMID: 10960635
OBJECTIVE: To determine whether human papillomavirus (HPV) DNA testing and risk assessment can predict cervical intraepithelial neoplasia (CIN) 2-3 on biopsies in women with atypia on Papanicolaou smears. ...The sensitivity of high-risk HPV for detecting CIN 2-3 was 93. 3% …
OBJECTIVE: To determine whether human papillomavirus (HPV) DNA testing and risk assessment can predict cervical intraepithelial neopl …
HPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia.
Bierkens M, Wilting SM, van Wieringen WN, van de Wiel MA, Ylstra B, Meijer CJ, Snijders PJ, Steenbergen RD. Bierkens M, et al. BMC Cancer. 2012 Jan 24;12:36. doi: 10.1186/1471-2407-12-36. BMC Cancer. 2012. PMID: 22273477 Free PMC article.
BACKGROUND: The development of cervical cancer and its high-grade precursor lesions (Cervical Intraepithelial Neoplasia grade 2/3 [CIN2/3]) result from a persistent infection with high-risk human papillomavirus (hrHPV) types and the accum …
BACKGROUND: The development of cervical cancer and its high-grade precursor lesions (Cervical Intraepithelial Neoplasia …
Diagnostic value of high-risk HPV other than type 16/18 in high-grade cervical neoplasia among cytology-negative women: A multicenter retrospective study.
Bai A, Xue P, Li Q, Jiang Y, Qiao Y. Bai A, et al. Cancer Med. 2023 Jul;12(13):14794-14805. doi: 10.1002/cam4.6109. Epub 2023 May 18. Cancer Med. 2023. PMID: 37199394 Free PMC article.
The evaluation of diagnostic value among HPV genotypes included the possibility of predicting cervical intraepithelial neoplasia grade 2/3 or worse (CIN2+/CIN3+) and the diagnostic efficiency measured by increased referral rate and …
The evaluation of diagnostic value among HPV genotypes included the possibility of predicting cervical intraepithelial …
World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer.
Santesso N, Mustafa RA, Schünemann HJ, Arbyn M, Blumenthal PD, Cain J, Chirenje M, Denny L, De Vuyst H, Eckert LO, Forhan SE, Franco EL, Gage JC, Garcia F, Herrero R, Jeronimo J, Lu ER, Luciani S, Quek SC, Sankaranarayanan R, Tsu V, Broutet N; Guideline Support Group. Santesso N, et al. Int J Gynaecol Obstet. 2016 Mar;132(3):252-8. doi: 10.1016/j.ijgo.2015.07.038. Epub 2015 Dec 14. Int J Gynaecol Obstet. 2016. PMID: 26868062
BACKGROUND: It is estimated that 1%-2% of women develop cervical intraepithelial neoplasia grade 2-3 (CIN 2-3) annually worldwide. The prevalence among women living with HIV is higher, at 10%. ...Systematic reviews of randomized controlle …
BACKGROUND: It is estimated that 1%-2% of women develop cervical intraepithelial neoplasia grade 2-3 …
The clinical and economic benefits of school-based quadrivalent HPV vaccination in Singapore.
Tay SK, Hsu TY, Shcheprov A, Walia A, Kulkarni AS. Tay SK, et al. Int J Gynaecol Obstet. 2017 May;137(2):129-137. doi: 10.1002/ijgo.12126. Epub 2017 Mar 10. Int J Gynaecol Obstet. 2017. PMID: 28190260
Strategy 2 included both girls and boys with no catch-up vaccination. Outcomes included the predicted incidence of HPV-related disease over 100 years. RESULTS: Current coverage was assumed to be 5%. Strategy 1 would reduce cervical intraepithelial neoplasia grade 1 (CIN1) …
Strategy 2 included both girls and boys with no catch-up vaccination. Outcomes included the predicted incidence of HPV-related diseas …
Assessing artificial intelligence enabled liquid-based cytology for triaging HPV-positive women: a population-based cross-sectional study.
Xue P, Xu HM, Tang HP, Wu WQ, Seery S, Han X, Ye H, Jiang Y, Qiao YL. Xue P, et al. Acta Obstet Gynecol Scand. 2023 Aug;102(8):1026-1033. doi: 10.1111/aogs.14611. Epub 2023 Jun 15. Acta Obstet Gynecol Scand. 2023. PMID: 37318036 Free PMC article.
MATERIAL AND METHODS: HPV-positive women were triaged using AI-LBC, human cytologists and HPV16/18 genotyping. Histologically confirmed cervical intraepithelial neoplasia grade 2/3 or higher (CIN2+/CIN3+) were accepted as thresholds for c …
MATERIAL AND METHODS: HPV-positive women were triaged using AI-LBC, human cytologists and HPV16/18 genotyping. Histologically confirmed c …
27 results